Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion

July 22, 2020 updated by: Sheila Ridner, Vanderbilt-Ingram Cancer Center

A Preliminary Pilot Study to Tailor and Evaluate the Feasibility of Child and Parent Yoga (CAPY) During Chemotherapy Infusion

This trial studies how well Yoga works in supporting children with cancer and their parents during chemotherapy infusion. Pediatric cancer and its treatment is one of life's most stressful events for children and their parents. Yoga is an ancient holistic healing science that incorporates postures, breathing, relaxation, and meditation to facilitate harmony between body, mind, and spirit. Participating in Yoga exercise may improve the negative psychosocial effects in children with cancer and their parents during chemotherapy treatment.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

PRIMARY OBJECTIVES:

  • To determine the feasibility of Yoga for children with cancer and their parents, specifically
  • Identify possible required modifications for safe and feasible practice during infusions.
  • Obtain recruitment estimates and determine barriers.
  • Assess satisfaction.

SECONDARY OBJECTIVES:

  • To determine the feasibility of administering and acceptability of measures to assess preliminary efficacy of Yoga for the following outcomes:
  • Child psychological distress (stress, anxiety).
  • Parent psychological distress (stress, anxiety, anger, depression).
  • Child and parent physiological stress (heart rate, respiratory rate, and blood pressure).
  • Parent-child communication.
  • Child physical symptoms.

OUTLINE:

Patients and parents participate in up to 8 Yoga sessions consisting of check in, awareness, breathing practices, gentle movement, and relaxation over 30 minutes each.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University School of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 17 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Children: 8-17 years of age, within 4 weeks of: 1) any new cancer diagnosis or newly diagnosed relapsed cancer, and 2) medical clearance who anticipate 3-weeks of continous contact with Monroe Carell Jr. Children's Hospital.
  • Parents: 18 years of age and older, child's primary caregiver (planning to attend appointments, infusions visits, or be in hospital rooms/clinics) or secondary caregiver (an as needed back-up to primary).

Children and Parents: able to speak and understand English, absence of cognitive impairment, and willing to engage in Yoga as part of a dyad.

Exclusion Criteria:

  • CHILDREN: Medical conditions that would prohibit the safe implementation of a Yoga practice
  • PARENTS: Practices Yoga weekly
  • PARENTS: Pregnant or plans to become pregnant during next 3 months
  • CHILDREN AND PARENTS: Unwilling to work as a dyad.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Yoga Therapy
Ancillary studies

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modifications
Time Frame: Up to 2 years
Will be assessed qualitatively. A tally of the specific modifications will be maintained to determine if particular modification are made more frequently than others.
Up to 2 years
Recruitment
Time Frame: Up to 2 years
The total number of eligible child-parent dyads approached to achieve an enrolled sample of 5 dyads will be tallied.
Up to 2 years
Retention
Time Frame: Up to 2 years
The number of the enrolled child-parent dyads who complete both the self-report assessments required at baseline (T1 - prior to first Yoga session), the Yoga protocol, and the measures at the end-of-infusion (T2 - prior to last Yoga session) will be tallied. The proportion completing will be used to inform the level of over-recruitment required in future studies of efficacy.
Up to 2 years
Barriers
Time Frame: Up to 2 years
Participants who do not complete the study will be contacted and queried as to the reason for the lack of completion. A tally of the specific barriers will be maintained to determine if particular barriers are encountered more frequently than others. This information will inform possible modifications required to the protocol in future research.
Up to 2 years
Participant satisfaction
Time Frame: Up to 2 years
The total number of responses to the 14 satisfaction questions with a rating > 4 (maximum rating = 7) will be generated for each of the 5 parent participants. It is expected that all participants will exceed that threshold for all questions. If not, frequency distributions will be used to summarize the responses to each of the 14 items to assess which produced the lower ratings. Responses to open-ended questions will be analyzed qualitatively. Findings from both components of the satisfaction survey (program satisfaction and yoga survey) will be used to revise the Yoga protocol as needed.
Up to 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child psychological distress
Time Frame: Up to 2 years
Will assess child distress using Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Psychological Stress Experiences- Short Form
Up to 2 years
Parent psychological distress
Time Frame: Up to 2 years
Will assess parent distress using the PROMIS Depression - Short Form
Up to 2 years
Parent psychological distress
Time Frame: Up to 2 years
Will assess parent distress using the PROMIS Emotional Distress - Anger - Short Form
Up to 2 years
Parent psychological distress
Time Frame: Up to 2 years
Will assess parent distress using the PROMIS Anxiety
Up to 2 years
Child and parent physiological stress
Time Frame: Up to 2 years
Will assess blood pressure
Up to 2 years
Child and parent physiological stress
Time Frame: Up to 2 years
Will assess heart rate
Up to 2 years
Child and parent physiological stress
Time Frame: Up to 2 years
Will assess respiratory rate
Up to 2 years
Parent-child communication
Time Frame: Up to 2 years
Will be assessed using the Parent-Adolescent Communication Scale (PACS). Participants answer 20-40 questions. A total score is calculated ranging from 20-100 with higher scores indicating more positive communication.
Up to 2 years
Child physical symptoms
Time Frame: Up to 2 years
Will be assessed using the PROMIS Pediatric Physical Stress Experiences -Short Form.
Up to 2 years
Parent psychological distress
Time Frame: Up to 2 years
Parent distress will be assessed using the NIH Toolbox Perceived Stress
Up to 2 years
Child psychological distress
Time Frame: Up to 2 years
Child distress will be assessed using the PROMIS Pediatric Anxiety - Short Form
Up to 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Terrah Akard, PhD, Vanderbilt University School of Nursing
  • Principal Investigator: Sheila Ridner, PhD, Vanderbilt University School of Nursing

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 7, 2019

Primary Completion (Actual)

June 29, 2020

Study Completion (Actual)

June 30, 2020

Study Registration Dates

First Submitted

July 17, 2019

First Submitted That Met QC Criteria

July 25, 2019

First Posted (Actual)

July 26, 2019

Study Record Updates

Last Update Posted (Actual)

July 24, 2020

Last Update Submitted That Met QC Criteria

July 22, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • VICC SUPP 1935
  • NCI-2019-04525 (Registry Identifier: NCI, Clinical Trials Reporting Program)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malignant Neoplasm

Clinical Trials on Questionnaire administration

Subscribe